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1. INTRODUCTION 
 
Indonesia is a developed country in southeast Asia, which has an enormous number 
of rainforests, around 140 million hectares. These rainforests are precious resource of 
medicines and have become the great asset for Indonesia. 
Indonesia is not only biologically rich landscape but also culturally vast number of 
ethnicities. Those different ethnicities and cultural groups have developed their own 
healthcare systems. For example, a particular plant species may be used to cure a 
disease by one ethnic group, but an ethnic group in a different region would use another 
plant to cure the same illness. Nowadays, many Indonesian people still use herbal 
medicine because they believe that it has less negative effect than chemical drugs. 
To cure many diseases, the herbal plants have been used for years in traditional 
medicine such as infections, fever, wound, and other diseases. According to biodiversity 
research a number of the herbal plant in Indonesia numbering is around 30,000, which 
can be used as the herbal medicine to treat various types of diseases. 
For example, cancer is one of the most severe ailments, The World Health 
Organization (WHO) released figure that 13% of all deaths in the world were caused by 
cancer. Every year, around 8.2 million people died because of cancer. For the next 20 
years, it is predicted that new incident of cancer, which requires special diagnosis and 
treatment, will rise by 70% 1. Those cancer diseases can empirically be cured by the 
herbal medicine in Indonesia. 
The investigations of anti-cancer agents from the plants have made swift progress 
and it had shown significant results. The anti-cancer compounds which have been found 
in the plants, and also found the semi-synthetic derivatives of natural product such as 
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vinblastine, vincristine, etoposide, paclitaxel, and docetaxel. Unfortunately, most of 
found drugs for the cancer have the following disadvantages : gastrointestinal disorders 
such as vomiting and diarrhea, immunosuppression, and the resistance to anti-cancer 
drug2,3. It is, therefore, necessary to explore the plants which have not been studied to 
find a new medicine with less or no side effects to treat cancer. 
In folk medicine, the cure for cancer is still unclear; therefore, the exploration of 
plants in traditional medicine might be more associated with the symptoms which 
appear in the cancer such as a lesion, nodule, tumour4. Because of that there are 
possibilities to explore the plants which have not used traditionally for anti-cancer. 
Therefore, both medicinal plants and non-medicinal plants should be explored to find 
the bioactive compound that can be used as a lead compound to make the drugs that 
have action for anti-tumour or related disease such as anti-inflammation and 
antiangiogenic. The plant that has not been used as a traditional medicine is  Vitex 
cofassus. and  have been used as medicinal plants are flowers of Cananga odorata, 
leaves of Moringa oleifera, leaves of Stachytarpheta jamaicensis (L), stems of 
Aquilaria sp., seeds of Lansium domesticum, leaves of Artocarpus communis, seeds of 
Azadirachta indica, leaves of Carallia brachiata, aerials part of Pseudelephantopus 
spicatus, leaves of Ficus benjamina, leaves of Chromolaena odorata, leaves of 
Cyanometra ramiflora , leaves of Spathodea campanulata, and leaves of Cordyline sp. 
5-7. 
In this research, the preliminary assay was performed for the screening of these 
plants, to find out the activities as the antiproliferative, anti-inflammatory, 
antiangiogenesis, and anti-HIV. 
By evaluating the antiproliferative activity of the plants, it suggests that a plants 
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could be used for further investigation as a potential anti-cancer agent. Since, the cancer 
is the cell which proliferate continuously because of the mechanisms that control the 
growth of cells fail, and the proliferation of the cells exceeds the normal cells.  
Several studies inform that the cancer had a link or correlation with other diseases, 
namely inflammation4, 8-11 which is one of the body innate immunity mechanisms 
against the incursion from outside such as microbe which can be represented by rash, 
fever, and sore8.  
The cancer development were subscribed from the chronic and permanent 
inflammation. its development could be associated with tumour-linked inflammation4, 
8-11. Furthermore, it is approximately that 25 % of all tumour incidents were correlated 
with infection and inflammation4. 
Recently, pathological conditions, such as premature senility occur because of 
degeneration of brain and vascular problems such as atherosclerosis and tumour, which 
were reported to have correlation with inflammation. Among other pathological 
conditions, The diseases can develop from the inflammation ailment to the cancer 
disease, such as colorectal tumour from bowel sickness, prostate cancer from prostatitis, 
hepatocarcinoma from liver cirrhosis4. 
Both inflammations and angiogenesis have the connection with the development of 
a tumour. The latter is an expansion of novel vessels from the presence vasculature 
which is a common physiological process occurring during embryonic stage, 
reproductive cycle of females, and wound healing11.  
In angiogenic disease, there are two possible scenarios: new blood vessels can grow 
excessively (e.g. cancer, diabetic retinopathy, and psoriasis) because the high numbers 
of angiogenesis factors were produced, such as vascular endothelial growth factor 
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(VEGF) and the rise of new vessels was inadequate to meet the physiological 
requirements (e.g. chronic wound and ischemia heart disease) because the angiogenesis 
growth factor was produced in limited number, and also the amount of angiogenesis 
inhibitor was abundant11. In conclusion, the angiogenesis proces is regulated by the 
balance of angiogenesis factors and its inhibitors which are tightly maintained11.  
If the first scenario of pathology angiogenesis occurred, it supports the development 
of cancer, because new vessel from angiogenesis will supply material such as oxygen 
and other material was needed for cancer cells to proliferate and be still viable12. 
Furthermore, the angiogenesis influences not only the tumour developed but also the 
metastases of tumour 13.  
An investigation was reported and a favourable outcome when the combination of 
antiangiogenic with chemotherapy was given to the patient who had tumour4. Also 
several drugs for antitumour which were obtained from plants have properties as 
antiangiogenic namely taxol, camphtotecin, and combrestatin11.  
The other studies, the UNAIDS was reported that the number of people that died 
because of the AIDS-related disease was up to 1.2 million, and the number of 
newly-infected reached 2 million people. Antiretroviral are the essential medicine for 
manage HIV disease, but it had many problems such as resistance, and side effects 
which is the same as the problem in cancer which is already mentioned before. In 
summary, to find medicine with effectiveness and no or less side effects is important. 
The plants have been proven as the source of medicine, therefore, by preliminary 
bioactivity anti-HIV of these plants will lead to further investigation to find new agents 
which are prospective as anti-HIV.  
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Aim of the study 
The clarification of the description above showed the importance to explore the 
plants to obtain compounds which have anticancer and other diseases related to 
anticancer activity such as anti-inflammation and anti-angiogenesis. Moreover, further 
newly studied plants that have bioactive agents is another purpose of conducting such a 
study. Therefore, the aim of this research is to study the potential benefits and to isolate 
bioactive compounds of Indonesian medicinal and non-medicinal plants. 
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2. RESULTS AND DISCUSSION 
 
2.1 Preparation of extracts for preliminary assay 
In this research, all of the 15 Indonesian plants were collected in 2013 from several 
regions in Indonesia, namely: Makassar (Celebes), Malang (East Java) and Fak-fak 
(West Papua). In this research, plants were divided into classifications of medicinal 
plants and non-medicinal plants (Table 1).  
The plants were extracted using methanol and water for preliminary assay, which 
produces water and methanol extract (Scheme 1). Processes of extraction are described 
as follows: the plants were washed with water to eliminate soil or other contaminant 
materials. They are then cut into small pieces to be dried at ambient temperature, after 
which, the plants are ground into a form of powder. Water extracts are prepared with 
water and heated for 30 minutes at a temperature of about 90℃. The extracts are then 
freeze-dried. Methanol extracts are prepared by adding methanol to the powdered 
materials, and then kept at an ambient temperature for 3 days. The methanol is later 
evaporated in vacuo to obtain a condensed mass. Extracts water and methanol were used 
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Table 1. Sample used in this study (collected: 2013) 









A. Medicinal plants    
BRG Ficus benjamina 
L. (Moraceae) 
















indica A. Juss. 
(Meliaceae) 




GHR Aquilaria sp. 
(Thymeleaeceae) 
















swelling of the 
lymph, cardiac, 
uric acid, and 
nephritis 
KNG Cananga odorata 










odorata (L.) R. 
M. King & H. 
Rob. 
(Asteraceae) 
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HJG Cordylinne sp. 
(Asparagaceae) 










Menzai Leaves Makassar 
South Celebes 


















us spicatus  (B. 




































KLR Moringa oleifera 
Lam. 
(Moringaceae) 
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B. Non-Medicinal Plant 









VCS Vitex cofassus  
Reinw. ex Blume 
(Lamiaceae) 






















Scheme 1 Preparation procedure for the methanol and water extract 
 
2.2. Bioactive screening activity of Indonesian plant extracts 
2.2.1 Anti-proliferative activity against human cancer cell line 
Tumour, cancer and proliferation are three concepts that are closely tied together. 
Cells in our body have their own mechanism to regulate growth, regardless of whether it 
is in the developmental phase or at maturity. The cells have specific programs in relation 
Water extract  Methanol extract 
Dried plants  
Fresh plants  
Washed  
Cut into small pieces 









 Freeze dry Evaporate in vacuo 
Put through grinder 
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to managing homeostasis which basically details the timing of growth or death of 
certain cells. For instance, the cells of skin will remain alive for 2 weeks which are then 
replaced by new cells. However, several cells in mature tissues are only proliferative in 
the period of recuperation which can be found in the hepar, heart, and neurone. If this 
mechanism fails to manage the cell growth process, the number of proliferation cells 
will start to rise, and this leads to the production of an abnormal amount of cells which 
could potentially trigger growth of cancer cells.14,15. 
This is because the proliferation or growth exceeds the normal amount of cells. And 
if they are still alive for a certain amount of time, they will begin to form a solid mass, 
namely a tumor, which has hypoxic properties. Tumours can be classified into two 
classes, firstly is a benign tumor which is easy to be treated, not harmful to the nearby 
cells, and will only be hazardous if it becomes larger. The second is a malignant tumor 
which is difficult to be treated, harmful to nearby cells as the proliferation is faster than 
normal cells, and it could also expand and sprout supplementary tumors. But there are 
some kinds of malignant tumors which are still dormant for a particular period such as 
those within the area of the ovaries and breasts. The second tumor is associated with 
cancer or neo-plasma. Consequently, it can be confirmed that cancer is caused by the 
growth of abnormal cells derived from tumors of which proliferation is uncontrolled. 
This is clearly because of the exceeding of the normal cells, being harmful to other 
nearby cells, making it highly difficult to be treated and could potentially expand to 
other organs in the body and sprout supplementary tumors or metastases14,15. 
Plants have been under investigation as a source of anti-cancer and research has 
shown significant results. Anti-cancers such as vinblastine, vincristine, etoposide, 
paclitaxel, and docetaxel are developed originally from plants or semi-synthetic 
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derivatives. Most of the exploration uses anti-proliferative assay on cancer cell lines3, 
16-17. 
An anti-proliferative assay against human cancer cell lines was performed using 
sulphorhodamine (SRB), a pink colour stain, and an amino xanthene with two sulfonic 
moieties. The mechanism of this assay is based on the amino acid in the cell absorbed 
by the negative charge of the stain. If the numbers of the cells are excessive, the greater 
the numbers of dyes are incorporated. The large amount of the absorbance appeared 
from the lysis of cells after staining because the liberated stain gave an intense colour. 
This assay has many advantages compared to other assays, as it is faster, easier, more 
sensitive, reproducible, and it is also time-independent to get to an end point which is 
constant or stable18-19. 
This assay uses human cancer cell lines which is one of the powerful model 
systems for assessing expectant anti-proliferative drugs. There are some advantages to 
using human cancer cell lines such as genuineness, simplicity in dissemination and it is 
also genetically exploitable. And considering the process and level of research are 
identical, then the outcome of the research is reproducible even after several 
experiments. Furthermore, if it is to be compared the oncogenic process between mice 
and humans might not be the same, and therefore, human cell lines are similarly 
oncogenic20-21. There were four human cancer cell lines used in this preliminary assay, 
namely: A549 (human lung carcinoma), KB (human epidermoid carcinoma), 
MDA-MB-231 and MCF-7 (human breast carcinoma).     
The result of this anti-proliferative assay is described comprehensively as seen in 
Table 2,  
Methanol extract of PDS revealed moderate inhibition on MDA-MB-231 of about 
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43.2 %, low inhibition on KB an MCF-7 and no inhibition on A549 cells. Water extracts 
of all of the plants have shown low to no inhibitory growth of all of the cell lines. 
Based on the description above, it was concluded that methanol extracts have better 
activity than water extracts, and the methanol extracts of KNG, GHR and PDS have 
shown significant results in anti-proliferative assay activity for further investigation. 
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Table 2. Antiproliferative activity of methanol and water extracts from fifteen 
plants  
 Sample 
 Cell growth inhibition (%)   
A549 KB MDAMB231 MCF7 
BRG-A 9.1 21.2 37.9 31.6 
BRG-B 0 0.2 21.9 17 
LGT-A 10.8 36.6 18.9 34.1 
LGT-B 0 2.9 2 2.7 
MBA-A 8.1 7.6 7 21.3 
MBA-B 0.1 6.2 3.8 12.1 
GHR-A 86.6 42.2 81.5 53.2 
GHR-B 0 0 13.1 9.2 
SKN-A 1.1 17.8 40.1 30.0 
SKN-B 0 0 0.7 3.3 
KNG-A 100 86.4 100 100 
KNG-B 0 2.1 4.8 3.8 
KPS-A 10.4 28.5 25.0 24.2 
KPS-B 0 0 10.6 3.7 
HJG-A 0 1.9 2.9 12.1 
HJG-B 0 0 0 1.7 
CBR-A 0 0 9.9 15.9 
CBR-B 0 4.3 13.5 12.1 
PKD-A 2.3 10.3 6.7 4.0 
PKD-B 0 0 0 4.2 
VCS-A 0 0 3.5 5.1 
VCS-B 3.0 3.0 19.8 17.7 
CMR-A 0.2 10.6 16.3 22.9 
CMR-B 0.6 0 11.9 8.7 
STC-A 0 8.5 20.9 13.8 
STC-B 0 0 6.6 12.5 
KLR-A 0 1.3 6.8 12.9 
KLR-B 0 2.8 3.1 13.1 
PDS-A 0 24.2 43.2 30.0 
PDS-B 0 0.6 25.7 9.3 
*PXL 6.6 6.2 10.1 9.6 








A549 : human lung carcinoma, KB : human epidermoid carcinoma, MDA-MB-231 and 
MCF-7 : human breast carcinoma 
Sample concentration : 20 µg/ml *PXL : Paclitaxel GI50 µM 
 
2.2.2Anti-inflammatory assay 
A large number of investigations on plants reported that an enormous number of 
compounds exhibited anti-inflammatory activity. In addition, secondary metabolites of 
plants usually influence one substance or instrument which involves inflammation. 
Many materials or instruments are included in the process of inflammation such as 
cytokines, Arachidonic acid (AA) metabolite pathways, peptides, nitric oxide (NO), 
NF-κB etc8. 
NO is one of the substances that are involved in the inflammation process, this 
substance is produced from L-arginine through oxidation of one enzyme that is known 
as NO synthase (NOS). This enzyme has two ways to generate NO. Firstly, the main 
process occurs as a reaction against stimulus, and then NO liberates for a brief period. 
This commonly happens in the physiological process of the body. This enzyme is 
known as constitutive NOS. The second enzyme is called inducible NOS (iNOS) which 
BRG : Ficus benjamina  
LGT: Lansium domesticum  
MBA : Azadirachta indica  
GHR : Aquilaria sp.   
SKN : Artocarpus communis  
KNG: Cananga odorata   
KPS: Chromolaena odorata  
A . Methanol extract 
B. Water extract 
 
HJG : Cordylinne sp.  
CBR : Carallia brachiata 
PKD : Stachytarpheta jamaicensis  
VCS Vitex cofassus  
CMR :Cynometra ramiflora  
KLR : Moringa oleifera   
STC : Spathodea campanulata  
PDS : Pseudelephantopus spicatus  
PXL : Paclitaxel 
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is authentically derived from macrophage and can also found in other cells such as 
neutrophil, mast and endothelial, but it has to be triggered by cytokines or 
lipopolysaccharide (LPS). It will then liberate NO constantly, and the amount of NO 
will be abundant22-24. 
Normally, NO is one of the innate immune substances which can counter-intrude 
externally and is also a controller for homoeostasis in the body. However, if it over 
produces and interacts with molecules in our body such as superoxide, it becomes 
peroxynitrate which can cause cell corruption while NO elevates the number of 
prostaglandin as a pro-inflammatory measure. This will lead to the increase in the 
number of several ailments such as inflammation, carcinogenesis, and 
atherosclerosis22-24. Consequently, inhibition of NO could be used as an evaluation 
method for delivering anti-inflammatory agents. 
 
2.2.2.1 Anti-inflammatory activity against LPS-induced J774.1 cells  
In this research, the NO inhibitory assay on LPS-induced  J774.1 cells as 
macrophage, it was discovered that these cells have similar properties as the regular 
macrophage. They can produce and liberate lysozyme and when they destroy cells, the 
object is determined by antibody. These cells were obtained from a BALB/c mouse 
which suffered from unpremeditated tumour. The J774.1 cells function as a macrophage 
and after being triggered by LPS from Escherichia coli, these macrophages could 
produce NO. Inhibition of NO was evaluated using griess reagent25-26 
Griess reagents were introduced in 1879, and these methods were widely used to 
examine nitric oxide in living specimens such as urine and blood, and also in a cell 
which is cultured in a medium. The process of griess reagents is established as follows: 
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initially, it will produce short-term diazonium salt which is produced from a reaction 
between nitrite and sufanilamide that is already added with acid, usually phosphoric 
acid. This short-therm salt becomes non-labile azo agents which has a strong purple 
colour, after adding a N-naphtyl-ethylenediamine. Afterwards, a microplate reader is 
used to measure the absorbant or optical density of high purple colour for NO 
concentration. The absorbant or optical density is calculated with an equation which 
will be explained later26. 
Results of the calculations of absorbant can be seen in Fig.1. There were nine 
methanol extracts of the plants that had a significant result on NO inhibitory activity of 
more than 80 % which were BRG, LGT, MBA, GHR, SKN, KNG, KPS, VCS, and PDS 
and the highest inhibitory activity was exhibited by KNG. The methanol extract of 
CMR exhibited moderate NO inhibition of about 65 %. Other methanol extracts 
presented low NO inhibition of under 30 %. 
Three water extract offered high NO inhibition of about 80-90 %, being KNG, KPS, 
and VCS. Five water extracts demonstrated moderate NO inhibition activity of about 
40-60 % which were GHR, SKN, HJG, CBR, and PDS. The rest of the water extracts 
revealed low NO inhibition activity, but two of the extracts performed no activity. 
Based on previous explanation, it could be summarized that three of the plants 
offered both of their extracts, water and methanol that had shown significant activity 
which were KNG, KPS, and VCS. Nine methanol extracts of plants showed positive 
result on NO inhibition for BRG, LGT, MBA GHR, SKN, KPS, VCS, PDS. However, 
the methanol extract of KNG exhibited the highest inhibition of NO. On the other hand, 
only three of the water extracts yielded positive results (KNG, KPS, VCS). All of these 
extracts could be explored for further investigation. 
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HJG : Cordylinne sp.  
CBR : Carallia brachiata 
PKD : Stachytarpheta jamaicensis  
VCS Vitex cofassus  
CMR :Cynometra ramiflora  
KLR : Moringa oleifera   
STC : Spathodea campanulata  
PDS : Pseudelephantopus spicatus  
BRG : Ficus benjamina  
LGT: Lansium domesticum  
MBA : Azadirachta indica  
GHR : Aquilaria sp   
SKN : Artocarpus communis  
KNG: Cananga odorata   
KPS: Chromolaena odorata  
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2.2.2.2 Cytotoxicity activity against J774.1 cells 
Quantification of colour that appears in a solution is defined as colorimetry.  
Accuracy, speed and its non-radioisotope nature are significant benefits of colorimetry 
assay. One of the colometry assays conducted is the MTT assay, which was introduced 
by Mosmann. The advantages of this assay are its non-radioisotope nature which is 
relatively safe, uncomplicated, and timely. It can also be used on a large number of 
samples, data of this assay can be calculated easily with a computer programme, and 
can be applied in a cell of which the preparation is in a non-dissolved medium or single 
layer27-29. 
MTT assay is established from a reduction of a stain such as a tetrazolium salt, 
3(4,5-dimethyl-thyazol-2-yl)2,5 diphenyltetrazolium bromide (MTT) by a 
dehydrogenase enzyme in mitochondrial from cells that are still alive. This reduction 
yields formazan, which cannot dissolve in water. Higher formazan would be produced if 
the used macrophage cell has already been activated by LPS. Formazan is dissolved 
using DMSO and optical density is quantified using a microplate reader, using two 
wavelengths: 630 nm for reference and 570 nm for sample. Lastly, the optical density is 
calculated using an equation which will be explained later27-31. 
Assessment of cell viability is performed by MTT assay on J774.1 cells that have 
been previously applied to the NO inhibitory assay. This assay was established to obtain 
the correlation between NO inhibitory activity and cytotoxicity against J774.1 cells. 
The output of optical density was calculated by equation which can be seen in Fig. 
2, and is described as follows. Seven methanol extracts of plants have shown no 
cytotoxicity on J774.1 cells such as GHR, SKN, CBR, PKD, STC, CMR, and KLR.  
Five methanol extracts showed low cytotoxicity with viability cells of about 80 - 90 % , 
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which were LGT, MBA, KNG, HJG, VCS. BRG and PDS exhibited moderate 
cytotoxicity. The methanol extract of KNG demonstrated cytotoxicity on J774.1 cells, 
and the cell viability was at about 40 %. Water extracts of all of the plants revealed low 
to no cytotoxicity against J774.1 cells. 
Based on the explanation of all the data above, it could be suggested that several 
plants have close linkages between cytotoxicity and NO inhibition activity which occurs 
in extracts of methanol of KPS, PDS, and BRG. Methanol extracts of KPS revealed 
cytotoxicity against cell J774.1, which suggests that inhibition of liberated NO caused 
the death of the cells. Methanol extracts of PDS and BRG also yielded the same results 
even though cytotoxicity was moderate.   
Some of plants did not imply correlation between cytotoxicity and the activity of 
NO inhibition. These plants were the methanol extracts of GHR and SKN and the water 
extracts of KNG, KPS, and VCS. From this data, it can be inferred that methanol 
extracts of GHR, SKN, BRG, KPS, PRS, LGT, MBA, KNG, VCS and also water 
extracts of KNG, KPS, and VCS can be investigated further.  
 
Fig. 2 Cytotoxicity using MTT assay on J774.1 cell  
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2.2.3 Anti-Angiogenesis assay on HUVEC   
In angiogenic diseases, there are two possible scenarios. The first being excessive 
growth of new blood vessels due to increased production of angiogenesis factors such as 
the vascular endothelial growth factor (VEGF). On the other hand, the rise of these new 
vessels could prove inadequate to meet physiological requirements (e.g. chronic wound 
and ischemia heart disease) because angiogenesis growth factors are produced in limited 
numbers, while angiogenesis inhibitors are abundant11. 
Angiogenesic factors namely vascular endothelial growth factor (VEGF) are a 
significant part of this angiogenesis process. By obstructing VEGF, it can hamper the 
process as well as the development of tumour related metastase34-35 An assay was 
developed to inhibit the VEGF by using HUVEC (human umbilical vein endothelial 
cells)12. 
The inhibition of VEGF by using HUVEC was performed in the Department of 
Clinical Biochemistry and second Department of Pharmacology, School of 
Pharmaceutical Science at the Kyushu University of Health and Welfare. 
Data of inhibition of VEGF using HUVEC can be observed in Fig. 3, and is 
described as follows: There were ten extracts of plants that did not inhibit VEGF. This 
was confirmed by their cell viability of more than 95 % such as water extracts of KPS, 
BRG, VCS, CMR, GHR, PKD, PDS and methanol extracts of KNG, CMR, PKD. There 
were six extracts of plants which inhibited VEGF. This was indicated by their cell 
viability of about 60 - 80 %, and also crocin as a positive control device had cell 
viability of around 66 %. The water extracts of SKN, CBR and methanol extracts of 
GHR inhibited VEFG but showed moderate cytotoxicity, supported by cell viability of 
about 40 - 50 %. Nine extracts inhibited VEGF with cytotoxicity to HUVEC because of 
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their cell viability of under 33 %, which were the water extracts of HJG, KPS, BRG, 
and methanol extracts of VCS, STC, KLR, SKN, CBR, PDS. Methanol extracts of 
MBA and LGT inhibited VEGF but were very cytotoxic to HUVEC, similar to Shikonin 
as a control device of which no cells were viable after the assay was done. 
It was revealed that the water extracts of KNG, MBA, STC, LGT, KLR and 
methanol extracts of HJG might be promising extracts for further investigation because 
they inhibited VEGF and no cytotoxicity against HUVEC cells.   
 
 
Fig. 3. Plants extracts inhibit VEGF-that induced change on viability of HUVECs 
1. Water extract，2. Methanol extract，ex) KPS1 is water extract of KPS 
 
2.2.4 Anti-HIV assay and Cytotoxicity  
   Human immunodeficiency virus (HIV) started as main problem in the health sector 
at the beginning of the 1980s all over the world. The World Health Organization 
reported an enormous number of people dying because of HIV, estimating over 34 
million in 2014, and the number of persons infected expected to increase. In 2014, there 
were around 36.9 million people infected with HIV. 
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Antiretroviral (ARV) medicine has been used globally as a countermeasure. 
Unfortunately, this drug only manages the virus and hinders the extension of the virus, 
but it does not destroy HIV. Because of that, it is important to explore our nature to 
obtain other forms of medicine, especially from plants that can be used to treat people 
infected with HIV.  
This assay was performed by using the MTT method and was carried out by the 
Medical College, Department of Microbiology at Duke University in the United States 
of America. 
The result of the assay (Table 3) will be described as follows: It is seen that four 
methanol extracts of LGT, GHR, KNG, VCS had a positive result in this assay. These 
were confirmed by effective concentration that prohibit 50 % of viral (EC50) production 
of around 1.5 - 12 (µg/ml). The water extract of HJG also showed significant activity, 
with EC50 of about 1.5 µg/ml. The most potent activity was seen in the methanol extract 
of GHR and water extract of HJG where no toxicity appeared in both of the extracts, 
confirmed by CC50 >20 µg/mL. The methanol extract of KNG revealed cytotoxicity, 
assured by CC50 of 12.5 µg/mL. Therefore, methanol extracts of GHR, LGT, and the 
water extract of HJG could be suggested for further investigation. 
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Table 3. Anti-HIV activity and cytotoxicity of plants  





BRG-A >20 2 >20 
BRG-B >20 1 >20 
LGT-A 12 2 >20 
LGT-B >20 1 >20 
MBA-A >20 2 >20 
MBA-B >20 1 >20 
GHR-A 1.6 2 >20 
GHR-B >20 1 >20 
SKN-A -* 1  
SKN-B >20 1 >20 
KNG-A 2.4 2 12.5 
KNG-B >20 1 >20 
KPS-A -* 1  
KPS-B >20 1 >20 
HJG-A >20 1 >20 
HJG-B 1.5 2 >20 
CBR-A -* 1  
CBR-B >20 1 >20 
PKD-A >20 1 >20 
PKD-B >20 1 >20 
VCS-A >20 2 >20 
VCS-B >20 1 >20 
CMR-A -* 1 >20 
CMR-B >20 1 >20 
STC-A >20 1 >20 
STC-B >20 1 >20 
KLR-A >20 1 >20 
KLR-B >20 1 >20 
PDS-A >20 1 >20 
PDS-B >20 1 >20 
AZT 0.008 2 >1 
Note:  1. Cells: MT4. Virus: NL4-3 
 2. Highest concentration tested = 20 µg/ml 
 3. -* : No selective anti-HIV-1 activity (CC50/EC50<5) 
CC50 is the concentration that prohibits 50 % of cells viability  
EC50 is the effective concentration that prohibits 50 % of viral production  
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Based on the data of assay that was performed, it is suggested that KNG, GHR, VCS, 
HJG, PDS, KPS are recommended for further investigation. VCS was chosen because it 
was the only plant that did not have any reports on pharmacological uses and 
constituents. Many other Vitex species that have been investigated all have reports on 
their pharmacological uses and constituents. The other reason is because after separation, 
one of the fractions which is fraction C (Table 6) had a significant result on cytotoxicity 
toward cancer cell lines even though it did not present any activity against cancer cell 
lines in the preliminary test. And also, it exhibited positive results as the inhibitory 
activity of NO against LPS-triggered J774,1 cells were notable at more than 80 %.  
 
2.3 Extraction, Isolation and Purification of Vitex cofassus 
In this research, the extraction, separation, and purification of VCS was done to 
obtain an isolated compound (Scheme 2). Several steps in these procedures were tested 
through cancer cell assays. The process of purification is described as follows; Dried 
leaves of Vitex cofassus was extracted by methanol in ambient temperature for three 
days and methanol solvent was removed by using an evaporator in vacuo to obtain a 
condensed mass. The mass then continued to separate water and CHCl3, (1:9). The 
CHCl3 layer was collected in a flask and the CHCl3 solvent was evaporated to gain 
extracts of CHCl3. The aqueous layer was proceeded with a partition of n-BuOH and 
each was accommodated for, and the n-BuOH extract was evaporated in vacuo to obtain 
n-BuOH extracts, while the water extracts were freeze dried to obtain water extracts. 
The CHCl3 extract continued to be separated because the cancer cell assay results 
were significant after being carried out. The CHCl3 extract was subjected to flash 
column chromatography on silica gel and was eluted using two combinations of 
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solvents. The first was CH2Cl2 and MeOH and the latter was CHCl3 and MeOH. Each of 
the combination of solvents was used to decrease polarity to obtain five fractions (A-E). 
Fraction C was chosen to be separated based on cancer cell assay data, which 
revealed positive results. Fraction C was chromatographed using flash column 
chromatography, using a decline in the concentration of a mixture solvent of CH2Cl2 and 
MeOH followed by CHCl3 and MeOH. The latter solvent used methanol to wash the 
column. Separation of fraction C delivered eight subfractions (C1-C8). Subfraction of 
C5 was rechromatographed using a similar solvent with fraction B by decreasing the 
concentration of the combination of the solvent of CH2Cl2 and MeOH followed by the 
solvent of CHCl3 and MeOH. The last solvent used MeOH to carry out on all of the 
extracts which still remained in the column. After separation, subfraction of C5 yielded 
nine subfractions C51-C59.  
Fraction C56 was loaded in Recycle HPLC to obtain five subfractions , and 
continued to purification which was performed in preparative TLC to obtain compound 



































Dried leaves of Vitex cofassus 
2.5kg (drymaterial) Extracted with MeOH 3 days 
Partition with CHCl3 and H2O  
CHCl3 Layer 27.8 g  
(1.2% from material) 
[100.9 % ; 29.97%] 
H2O Layer 
MeOH extract 243.0 g (9.0 % from dry material) 
n-BuOH Layer 77.2 g 
(3.1% from material) 
[-35.5% ; 32.8%]  
H2O Layer 66.5 g (2.7% 
from material) [-17.0% ; 
118.9%]  
(Percentage from material) 
[percentage of NO inhibition;cytotoxicity on J774.1 cell] 
Concentration sample 100 µg/mL  
Purification procedure (1) 
 
Partition with 
n-BuOH and H2O 
and H2O  

























CHCl3 27.8 g 
 (1.2% from material) 
FA 7.4 g FB 1.3 g FC 10.0  g FD 5.2 g FE 2.1 g 
Percentage of inhibitory proliferation Cancer cell line 
A549  MDA-MB-231   KB  KBVIN  (20 µg/ml) 
    100   100           65.8  82 (%) 
 
Purification procedure (2) 
SiO2 Sepacore 100 g 
 
CH2Cl2-MeOH 
(95:5) (97:3) (98:2) (99:1) (95:5) (90:10) MeOH (97:3) 
CHCl3-MeOH 




























C4   
0.3 g 
Purification procedure (3) 
FC (10 g) 
SiO2 Sepacore 100 gram 
C1   
0.2 g 
C3    
1.5 g 
C5    
4 g  
C6    
0.4 g 
C7    
0.24 g 
C8    
0.2 g 
SiO2 Sepacore 100 gram 
C51   
416.8 
mg 
C52   
590.0 
mg 
C53    
550.0 
mg 
C54    
560.0 
mg 
C55   
88.6 
mg 










 0.6  g 
CH2Cl2-MeOH 





(99:1)  (98:2) (95:5) (93:7) (MeOH) 
CH2Cl2-MeOH 
(80:20) (85:15) (70:30) 
CHCl3-MeOH 
(98:2) (95:5) (93:7) (MeOH) 
















0.106 g 0.0413 g 1.7 mg 
6 mg 
1 




Purification Procedure (4) 
16.5 mg 
2 
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2.4 Identification of Isolated compound 






HMBC correlation ............ 
COSY correllation .......... 





Compound 1  
solvent : (CD3)2SO   
 
Compound 1  
solvent : (CD3)2CO   
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The description of compound 1 was given as a yellowish syrup and gives the 
molecular formula of C20H28O5 , as deduced from HRFABMS at m/z 349.2017 (calcd. 
for 349.2015) [M+H]+. The IR spectrum displayed absorption due to hydroxyl (3016 
cm-1), α,β-unsaturated aldehyde (1651 cm-1), and α,β-unsaturated γ-lactone carbonyl 
(1759 cm-1) groups. 
The structure of compound 1 was clarified by using 1D, 2D NMR, compared to the 
previous work and also the molecular formula which has been aforementioned. The 
NMR data (Table 4), (HMBC and COSY in Fig.5) is described as the following:     
The 1H NMR spectrum exhibited the presence of four methyl groups, including one 
olefinic methyl at δH 2.07 (3H, brs, CH3-18), two tertiary methyls at δH 0.97 (3H, s, 
H-19) and 0.902 (3H, s, H-20), and a secondary methyl at δH 0.896 (3H, d, J = 7.2 Hz, 
H-17). The 13C NMR experiment revealed the presence of 20 carbons, including four 
methyls, four methylenes, two methines, three oxy-methines, a sp2 methine , two 
quaternary carbons, two olefinic quaternary carbons, and a carbonyl carbon. 
Furthermore, α, β-unsaturated aldehyde function can be clarified by the 1H NMR 
spectrum that yielded an aldehyde proton at δH 9.97, which was connected by HMQC 
with the peak at δc 188.9. The connection, by a long range connection (HMBC) analysis 
between H-3 with C-1 and C-2, also confirmed α, β-unsaturated aldehyde function. 
Further analysis by using long range connection (HMBC) helped in determining the 
location of four methyl moieties such as CH3-17, revealing a correlation with C-7, and 
C-8, and CH3-20 with C-8, C-9, C-10, and C-11. 
The existence of the α-β-unsaturated-γ- hydroxybutenolide group was assumed by 
the spectrum of 13C NMR which revealed a hemiacetal carbon at ca. δc 98.3 (C-16), two 
sp2 carbons at ca. δc 117.3 (C-14) 170.9 (C-13), a carbonyl carbon at δc 175.6 (C15). 
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The connection between the group of the norclerodane structure and 
hydroxybutenolide was assisted by a two-atom aliphatic chain from a cross peak in the 
1H-1H COSY NMR spectrum between H-11 and H-12 and of H-20 with C-11 in the 
HMBC experiment.   
As aforementioned, the structure of compound 1, which was confirmed with the 
related compound, Xu et.al36 reported that a clerodane-type diterpenoid, 
pentandralactone [2-formyl-12S, Hydroxy-A-norclerodane-2,13(14)-dien-15,16-olide], 
was isolated from Callicarpa petandra36 and had almost similar NMR spectral features 
to compound 1. However, compound 1 had a bigger atomic mass unit (amu), and 
several spectrums were slightly different, except for signals on the C-16 side chain. 
Major NMR spectral differences in benzene–d6 between the two compounds were 
found in H-16 and C-16, both of which became downfield shifts sighted at δC 6.24 (1H, 
s) and δ c98.3 (C) and the previous pentandralactone showed at δC 4.82 (2H, d) and δC 
70.2.  
The absolute stereochemistry of C-12 from compound 1 was concluded as 5R, 8R, 
9S, 10R and 12S. By using the ECD analysis (Fig. 6) and the 13C-NMR preview (Table 
4), we deduced the configuration of a hemiacetal moiety at C-16 was around a 4:1 ratio 
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NO. δ H (J in Hz) δ C 
1. 2.11, 2.45 (2H, m) 26.6 
2.  137.8 
3. 9.97 (1H, s) 188.9 
4.  172.0 
5.  51.6 
6. 1.45 (1H, td, 12.6, 4.2) 
1.70 (1H, dt, 12.0, 3.3) 
34.7 
7. 1.53 (2H, m) 30.4 
8. 2.18 (1H, m) 38.6 
9.  39.5 
10. 1.89 (1H,dd, 11.4, 5.4) 54.7 
11. 1.58, 1.74 (2H,m) 45.0 
12 4.72 (1H, brs) 65.6 
13.  170.9 
14. 5.98 (1H,brs) 117.3 
15.  175.6 
16. 6.24 (1H,s) 98.3 
17. 0.896 (3H, d, 7.2) 16.2 
18. 2.07 (3H,brs) 9.6 
19. 0.97 (3H,brs) 17.3 
20. 0.902 18.7 
















Fig. 6 Calculated and experimental ECD spectra of 1 in acetonitrile 
The experimental Electronic Circular Dichroism (ECD) spectrum (solid line) of 1 was 
the closest to the calculated ECD spectrum of (5R, 8R, 9S, 10R, 12S, 16R) isomer 1a 
(dashed line). The best matched spectrum was observed when 1a and 1b were mixed at 
a 4:1 ratio.  
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2.4.2 Compound 2 (Acuminolide) 
Compound 2 was identified by comparing 1H-NMR and 13C-NMR data using the 
same solvent, similar to previous research as CDCl3+CD3OD (9:1. It has shown a near 
identical chemical shift37. NMR Data of Compound 2 can be seen in Table 5. 
Tabel 5. NMR data of compound 2 (Reference Lee )37 
no δ C δ H (J in Hz) δ C37 δ H (J in Hz)37 
1 39.8 1.12 (1H, t 12-6) 
1.52 (1H, m) 
39.7 1.11 (1H, ddd, J =13.0, 3.4 Hz) 
1.51 (1H, m H-1b) 
2 18.5 1.68 (1H, dd, 24.6, 13.2) 
 
1.49 (1H, m) 
18.4 1.67 (1H, ddddd, J =13.5, 13.5, 
13.5, 2.4, 2.4 Hz,) 
1.47 (1H, m, H-2a) 
3 42.3 1.43 (1H, m) 42.2 1.43 (1H, m) 
4 33.1  33.1  
5 57.2 1.02 (1H, 12.6) 57.1 1.01 (1H, dd, J =12.3, 2.4 Hz,) 
6 20.4 1.29 (1H, m) 20.3 1.82 (1H, m) 
7 34.3 1.83 (1H, m) 34.2  
8 84.7  84.7  
9 61.2 1.81 (1H, m) 61.0 1.80 (1H, m) 
10 36.5  36.4  
11 29.2  29.1  
12 74.5 4.90 (1H, d.9) 74.2 4.93 (1H, dd, J =7.6, 7.6 Hz,) 
13 170.1  169.0  
14 116.9 6.08  117.2 6.02 (1H, s) 
15 171.4  170.9  
16 98.6 6.16 (1H) 98.4 6.26 (1H, br, s) 
17 62.5 3.66 (1H) 62.3 3.66 (1H, d, J =11.0, 2.4 Hz,) 
18 33.4 0.88(3H,5) 33.4 0.88 (3H, s) 
19 21.1 0.83(3H,5) 21.0 0.83 (3H, s) 
20 15.6 0.79(3H,5) 15.5 0.80 (3H, s) 
OAc  --   --  
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2.5 Bioactivity of isolated compounds from Vitex cofassus 
2.5.1 Antiproliferative activity of Isolated compounds of Vitex cofassus 
 This research was conducted to discover a novel compound as anticancer by using 
antiproliferative assay on cancer cell lines. VCS was explored even though the 
preliminary screening using water and methanol extractions showed no significant 
results. But one of the fractions, namely Fr.C revealed antiproliferative on A549, 
MDA-MB-231, KB, KB-VIN after they were separated, the data can be seen in Table 6. 
Further investigation of this fraction yielded two identified compounds. By using SRB 
antiproliferative, a cancer cell line assay was performed on the isolated compounds and 
Both of the compounds indicated significant activity against all of the human cancer cell 
lines that show IC50 values ranging from 5.4 -11.4 µM. Compound 1 also indicated 
significant activity for the cancer cell lines that are resistant towards cancer drug 





 Inhibition (%) 
Cancer cell Lines 
A549 MDA-MB-231 KB KB-VIN 
1 Fraction C 100.0 100.0  65.8 82.0 














KB KB-VIN MCF-7 
1 Compound 1 10.0 6.4 9.9 11.4 11.0 
2. Compound 2 6.5 5.4 7.4 8.4 8.9 
3. PTX (nM)c 5.8 6.4 5.0 1421.9 8.5 
Table 7. Antiproliferative activities of Isolated compounds 
aAntiproliferative activity expressed as IC50 which is the concentration of compound 
that caused 50% reduction relative to untreated cells as determined by the SRB assay. 
bHuman tumor cell lines: lung carcinoma (A549), triple-negative breast cancer 
(MDA-MB-231), estrogen receptor-positive breast cancer (MCF-7), epidermoid 
carcinoma (KB), vincristine-resistant KB subline (KB-VIN).  
cPaclitaxel as experimental control. 
 
2.5.2 Antiangiogenesis assay of isolated compound of Vitex cofassus  
 Both compounds were examined by antiangiogenesis assay. Compound 1 
prevented VEGF-stimulated HUVEC proliferation in a dose dependent manner, 
indicating that 1 might have antiangiogenic activity but no signs of cytotoxicity 
appearing on the HUVEC (Fig. 7). Compound 2 was cytotoxic against HUVEC with 
cell viability of around 47 % at concentration 3 µM (Fig. 7).  
Nowadays, many drugs are used to cure cancer. Unfortunately, most of them have 
side effects, mainly gastrointestinal toxicity such as vomiting, diarrhea, etc. Metastases 
is one of the cancer cells’ ability that can be prevented with antiangiogenic. It is 
suggested that compound 1 is a promising substance that can be used as a lead 
compound for anti-cancer for further investigation because it has features of 
antiangiogenic, non-toxicity, and anticancer activity which are all potent for cells 
already resistant to chemotherapy such as KB-Vin. 
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3. SUMMARY 
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3. SUMMARY 
This research has revealed that 15 kinds of Indonesian plants show various 
antiproliferative activities by using preliminary screening against four cancer cell lines, 
namely: A549, KB, MDA-MB-231, MCF7. An anti-inflammatory assay that inhibited 
production of NO and MTT assay on J774.1 cells and an antiangiogenesis assay on 
HUVEC were conducted. The aim was to study the potential benefits and to isolate 
bioactive compounds of Indonesian medicinal and non-medicinal plants. Methods: The 
plants were extracted using methanol and water for the preliminary assay. The 
preliminary assay was performed in this research for the screening of these plants. 
Antiproliferative activity was evaluated with an RSB assay, anti-inflammatory activity 
was examined with inhibition of NO production on LPS-induced J774.1 cells, 
anti-angiogenesis was performed on the inhibition of VEGF on HUVEC, and anti-HIV 
was investigated by MTT assay. Based on the data of the assays, specific plants were 
chosen for extraction, isolation and purification to create isolated compounds. The 
isolated compound identified the structure and evaluated the activity by using an 
anti-proliferative activity on several cancer cell lines. Anti-inflammatory activity was 
examined by inhibition of NO production on LPS-induced J774.1 cells. 
Antiangiogenesis assay was performed on inhibition of VEGF on HUVEC, and 
anti-HIV assay was conducted on Cells MT4 and virus NL4-3. 
Result: It is recommended to further investigate the following six plants which are KNG, 
GHR, VCS, HJG, PDS, and KPS because they have shown significant activity during 
the preliminary assay. The outline of preliminary research is described briefly, as 
follows. The methanol extraction of flower buds of Cananga odorata (KNG) showed 
bioactivity during most assays, except for the angiogenesis assay. However, the water 
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extract of KNG displayed inhibitory activity on VEGF and cytotoxicity on HUVEC. As 
a result, both KNG extracts could be used as one of the plant candidates for further 
investigation. 
The methanol extract of Barks of Aqularia sp (GHR) was relatively active in all of 
the examination cells. It had bioactivity that could inhibit VEGF but showed moderate 
cytotoxicity against HUVEC cells because of cell viability of around 40 % in the 
anti-angiogenesis assay. The methanol extract of the aerials of Pseudelepanthopus 
spicatus (PDS) showed medium anti-proliferation on the MDA-MB-231 cell line where 
the growth of the cell was around 56.8 %. It also displayed bioactivity in the 
anti-inflammatory assay that showed NO inhibition of around 95%. But it was, however, 
cytotoxic against HUVEC where cell viability was only at 15 %. 
Water extracts of leaves of Cordyline sp. (HJG) showed evidence of a selective 
anti-HIV-1 activity. It had cytotoxicity against HUVEC cells, but methanol extracts of 
HJG inhibited VEGF and no cytotoxicity appeared against HUVEC. Cell viability was 
around 60 %. This value was almost identical with crocin as a positive control device in 
this assay. Both extracts of the leaves of Chromolaena odorata (KPS) shown indicated 
significant results in anti-inflammatory activity that inhibited NO of around 95 % and it 
had cytotoxicity against J774.1 cells. This was explained by the inhibition of NO which 
caused the cells to die.  
Meanwhile, the methanol extracts of leaves of Vitex cofassus (VCS) exerted 
positive results during the HIV test using 7.7 (µg/ml) of EC50. Both extracts of the VCS 
showed a significant anti-inflammatory effect as it could inhibit NO liberation on 
LPS-induced J774.1 cells of around 80 % and low cytotoxicity during MTT assays 
using J774.1 cell at around 80 %. 
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Therefore, VCS was chosen for further investigation because it was the only plant 
that has yet to be explored. And also, one of the fractions after separation exhibited 
significant results against human cancer cell lines where the chloroform-soluble part of 
VCS was performed on silica gel flash column chromatography, recycle HPLC, and 
preparative TLC to derive 2 compounds. Both of the compounds were identified using 
Mass spectrum analysis, 1H-NMR, 13C-NMR, 2D NMR, ECD experiments and were 
compared with previous research. Compound 1 was identified as 
(3aR,6R,7S,7aR)-7-{(S)-2-hydroxy-2-[(R&S)-2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl]et
hyl}-3,3a,6,7-tetramethyl-3a,4,5,6,7,7a-hexahydro-1H-indene-2-carbaldehyde (IUPAC), 
namely 16-hydroxy-pentandralactone. Compound 2 can be identified as acuminolide. 
Both of the compounds were examined through the antiproliferative assay against five 
human cancer cell lines such as A549, MDA-MB-231, KB, KB-Vin, MCF-7. 
Compound 1 and compound 2 showed bioactivity against five cancer cell lines, with 
IC50 5.4 – 11.4 µM (Table 7). Antiangiogenesis assay was also performed on both of the 
extracts, and compound 1 inhibited VEGF in a dose-dependent manner, but displayed 
no cytotoxicity against HUVEC. Compound 2 had cytotoxicity against HUVEC with 
cell viability around 47 % at concentration 3 µM. 
 
  Conclusion: Six plants can be used as candidate plants for further examination 
because they show significant activity, which are flowers buds of Cananga odorata, 
stems of Aquilaria sp., seeds of Azadirachta indica, aerials of Pseudelephantopus 
spicatus, leaves of Chromolaena odorata, leaves of Cordyline and leaves of Vitex 
cofassus sp.
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   compound 1 was identified as (3aR,6R,7S,7aR)-7-{(S)-2-hydroxy-2-[(R&S)-2- 
hydroxyl-5-oxo-2,5-dihydrofuran-3-yl]ethyl}-3,3a,6,7-tetramethyl-3a,4,5,6,7,7a-hexahy
dro-1H-indene-2-carbaldehyde (IUPAC), namely 16-hydroxy-pentandralactone could be 
explored as an agent for anti-cancer because it exhibited bioactivity against five cancer 
cell lines lung carcinoma (A549), triple-negative breast cancer (MDA-MB-231), 
estrogen receptor-positive breast cancer (MCF-7), epidermoid carcinoma (KB), 
vincristine-resistant KB subline (KB-VIN) with IC50 6.4 -11.9 µM. Compound (1) also 
showed evidence of ability in assisting in problem-solving in multi-resistant drugs 
because it showed activity on cancer cells that are resistant to chemotherapy such as 
KB-VIN. This is supported by antiangiogenesis data which inhibited VEGF in a 
dose-dependent manner, but no cytotoxicity appeared on the HUVEC.Compound 2 
exhibited significant activity against all the tested tumour cell line, and the IC50 5.4 – 
8.9 µM and also had cytotoxicity against HUVEC with cell viability of around 47 % at 
concentration 3 µM. 
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4. MATERIALS AND METHODS 
 
4.1. Anti inflammatory Assay 
4.1.1 Reagents 
Cell culture medium {RPMI-1640 (Gibco), fetal bovine serum (FBS) 
penicillin-streptomycin (WAKO)}, 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyl 
tetrazolium bromide (MTT), DMSO specification grade cell culture, Phosphate buffered 
salt (PBS) A griess reagent (sulphanilamide and N-1-Napthylethylene-diamine 
dihydrochloride wako), the degree of the solvent and chemicals were all the analytical 
standards. 
 
4.1.2 Cell culture 
J774.1 cell lines from murine macrophage were preserved in the laboratory using 
cell culture medium {RPMI-1640 (Gibco), fetal bovine serum (FBS) 
penicilin-streptomycin} in a CO2 incubator which was humidified, set to a temperature 
of 37 degrees Celsius, while concentration of CO2 was around 0.5 %, The cell was kept 
to sprout for the next investigation. 
 
4.1.3 Anti-inflammatory activity against LPS-induced J774.1 cells 
J774.1 murine macrophage cells were put into to 96 well plates, 100µL for each of 
the wells. They were then incubated in the CO2 incubator for 24 hours. The next day, the 
sample was prepared and divided into two parts, the first one contained LPS, while the 
other one did not. The plate was moved out of the incubator, and the old medium was 
removed and replaced with the already prepared sample. The plant extract or isolated 
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compound was incubated again for 24 hours. 
On the third day, a griess reagent was made by mixing sulphanilamide with 
N-1-Naphtylethylene-diamine dihydrocloride. It was later dissolved in some water 
which contained phosphoric acid, after which more water was added. Around 100 µl of 
griess reagent was put in new 96 plates. 
The cell plates were taken out from the incubator, kept in an ice box and 100 µl was 
relocated to the griess reagent plate. By using a microplate reader, the absorbents from 
the sample in the griess reagent plate were generated and then calculated to obtain the 
percentage of NO inhibition.  
 
4.1.4 Data analysis 
All data were calculated using the equation 
{ Ave A+ LPS} - {AveA-LPS} 
NO inhibition Ratio (%) = 1 -       X 100 
{Ave C + LPS} - {Ave C- LPS) 
Ave : average 
A : Sample (Optical density 560 - optical density 620) 
C : Control  (Optical density 560 - optical density 620) 
LPS: lipopolysaccharide 
 
4.1.5 Cytotoxicity activity against J774.1 cells 
After measuring the microplate reader (NO inhibition assay), the same plate was 
utilized for the MTT assay. 10 µl of MTT solution (5mg/ml) was set into the plate to be 
incubated for 2-4 hours in the CO2 incubator. The medium was removed and 200 µl of 
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PBS was added. After one minute, the PBS was removed. About 200 µl of DMSO was 
added to the plate to dissolve the formazan crystal that originally came from a reduction 
of MTT by enzyme dehydrogenase in the mitochondrial cell. The result was moved to a 
new plate, and the absorbance was quantified using a microplate reader at 570 nm. 
Lastly, the result was calculated to obtain viability of the cell in each of the samples. 
 
4.1.6 Data analysis 
All data were calculated using the equation:  
Asample optical density 
% of Cytotoxicity =      1 -        x 100 
Ccontrol optical density 
 
4.2.  Extraction, separation, isolation 
4.2.1 General experiments procedures 
1H NMR and 13C NMR were derived using JEOL ECA 600 (JEOL, Japan). Mass 
spectra was performed on a Jeol JMS-700 mass spectrometer (JEOL Japan) or JEOL 
JMS SX-102 (JEOL Japan). Flash column chromatography was conducted on biotage 
snap cartridge (Biotage), silica gel 60 N 63-210µm, with a buchi pump controller C-610.  
A preparative thin layer of Chromatography was carried out on glass plates, precoated 
using silica gel 60 F254 (Merck). Recycle HPLC was performed in LC908 recycle HPLC, 
λ 210 nm (JAI, Japan Analytical Industry). Thin layer chromatography was conducted 
on silica gel 60 F254 and RP-18 F254s (Merck Co., Germany).  
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4.2.2 Plant Material 
All of the plants were collected in Indonesia. The identification of the plants was 
performed in the Moslem University of Indonesia and the Indonesia Institute of Science. 
 
4.2.3 Extraction and Purification 
4.2.3.1 Extraction of Indonesian plants 
All of the plants were washed with water to clean them of soil or other substances 
that could contaminate them. They were then chopped into small parts and dried at 
ambient temperature to protect them from further light.  It was later crushed into 
powder form. Preliminary tests for the plants were carried out in two kinds of extracts, 
namely a water extract and a methanol extract.  
1. The water extract was made by adding water to powder plants, then heating it for 30 
minutes at a temperature of about 90℃. The water extract was then freeze dried. 
2. The methanol extract was prepared by adding methanol to powder plants, then storing 
it at an ambient temperature for three days. The solvent was replaced every day and 
stirred occasionally. The methanol extract was then was evaporated in vacuo to obtain a 
condensed mass. 
 
4.2.3.2 Purification of Vitex Cofassus 
Extraction, separation, and purification of VCS were performed to obtain isolated 
compounds (Scheme 2). Cancer cell assays evaluated some results of these procedures. 
The process of extraction until purification is described below. 
Dried leaves of Vitex cofassus, weighing 2.5 kg were entirely extracted using 
MeOH at ambient temperature for three days. Each day, methanol was replaced and 
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sometimes stirred. The methanol solvent was shrunken to become a viscous (243 g) 
mass using an evaporator which decreased its size in the vacuum.  The mass was 
proceeded to create a partition with water and CHCl3 (1:9) where the CHCl3 layer was 
collected in a flask, and the CHCl3 solvent was evaporated to gain a 27.7 g CHCl3, 
extract. The aqueous layer was proceeded to create another partition with a n-BuOH 
extract, and each of the layers were accommodated, and the n-BuOH extract was 
evaporated in vacuo condition to obtain a 77.15 g n-BuOH extract while the water was 
freeze-dried to obtain 66.5 g of the water extract. 
The chloroform extract was separated continuously because the result of the assay 
was significant after being carried out on the cancer cell. The CHCl3 extract was 
subjected to flash column chromatography on silica gel and eluted using two 
combinations of solvents. Each of the combination solvents was used to decrease in 
polarity. The first was CH2Cl2 :MeOH ( 99:1, 98:2, 97:3, 95:5 93:7), and after that 
CHCl3: MeOH, (95:5, 90:10). The latter solvent used methanol to obtain all of the 
compounds which remained in the column. The CHCl3, separation afforded five 
fractions A- E of which the amounts are 7.37 g, 1.31 g, 10 g, 5.17 g, 2.11 g respectively. 
Fraction C (10 g) was chosen to be separated based on cancer cell assay data, which 
revealed positive results. Fraction C was chromatographed using flash column 
chromatography. Using a declined concentration of mixture solvent of CH2Cl2 :MeOH 
(99:1 98:2 97:3 94:6) followed by CHCl3: MeOH (99:1, 98:2, 95:5, 93:7), the methanol 
solvent was applied to wash the column. Separation of fraction C delivered 8 
subfractions (C1-C8), and the largest amount was subfraction C5 amounting up to 4 
grams. Subfraction of C5 was rechromatographed using a solvent, described as follows. 
The concentration of combination solvent of CH2Cl2 :MeOH (80:20, 85:15, 70:30) was 
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decreased. This then continued with CHCl3: MeOH,(99:1, 98:2, 95:5), and the last 
solvent used methanol to carry out all of the extracts’ constituents, which still resided in 
the column. After separation, Subfraction C5 yielded 9 sub fractions C51-C59. FC56 
(0.64 g) and FC59 (0.1 g) were selected for further separation. All of the fractions were 
gathered as a basic fraction of their identical chemicals on TLC which was undertaken 
in UV 254 nm and sulfuric acid of 5% in MeOH, which was heated.   
Fraction C56 was loaded in Recycle HPLC to obtain 5 subfractions , and continued 
to be purified which was performed in Preparative thin layer Chromatography to obtain 
1 (6 mg) and 2 (8.2 mg) compound. 
 
4.3 Calculation of ECD spectrum 
The most stable conformer of 1 was predicted using Spartan’14 by a inititatory 
conformational analysis with the MMFF94 force field followed by geometry 
optimization using Gaussian0938 with the density functional theory (DFT) 
B3LYP/6-31G(d). The ECD spectrum in acetonitrile was calculated for the predicted 
most stable conformer by the time-dependent DFT (TDDFT) with the 
CAM-B3LYP/SVP. The solvent effect was presented by the polarizable continuum 
model (PCM). Ten low-lying excited states were projected. The projected spectrum was 
displayed using GaussView 5.0.920 with the peak half-width at half height being 0.333 
eV. The projected spectrum was shifted by +10 nm to match the experimental spectrum. 
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one yellowish syrup, where the mass spectrum analysis of compound 1 made use of 
fasting atom bombardment (FAB) which established the molecular formula C20H28O5 
and m/z 349 [M+H]+. Spectroscopi data (1H NMR and 13C NMR, 600 MHz), can be 
seen in Table 3 for (CD3)2CO. The most stable conformer of 1 was predicted using 
Spartan’14 by a inititatory conformational analysis with the MMFF94 force field 
followed by geometry optimization using Gaussian0938 with the density functional 
theory (DFT) B3LYP/6-31G(d) 
 
Known compound 2 
Acuminolide 
Colorless needles, where the mass spectrum analysis of compound 1 made use of 
fasting atom bombardment (FAB) which established the molecular formula C20H30O5 
351.2093, [M+H]+. Spectroscopi data (1H NMR and 13C NMR, 600 MHz) can be seen in 
Table 5 
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6. APPENDIX 






































X : parts per Million : 13C














































































































13C NMR spectrum of 1 in (CD3)2CO 
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HMQC spectrum of 1 in (CD3)2CO 
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9 project Y 
 
NOESY spectrum of compound 1 (CD3)2CO   
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13 C NMR spectrum of 1 in (CD3)2SO 
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HMBC spectrum of 1 (CD3)2SO  
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HMQC spectrum of 1 (CD3)2SO  
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COSY spectrum of 1 (CD3)2SO 
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1H NMR spectrum of 2 in CDCl3+CD3OD (9:1) 
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1C NMR spectrum of 2 in CDCl3+CD3OD (9:1) 
 
